Hirsutism cost-effectiveness of therapy

Hirsutism Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hirsutism from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Echocardiography or Ultrasonography
Treatment
Medical Therapy Pharmacological therapy Non-pharmacological therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hirsutism cost-effectiveness of therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hirsutism cost-effectiveness of therapy
CDC on Hirsutism cost-effectiveness of therapy
Hirsutism cost-effectiveness of therapy in the news
Blogs on Hirsutism cost-effectiveness of therapy
Directions to Hospitals Treating Hirsutism cost-effectiveness of therapy
Risk calculators and risk factors for Hirsutism cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Rasam Hajiannasab M.D.[2]

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Cost-effectiveness of Therapy

Oral contraceptives, finasteride, spironolactone and cyproterone acetate are known to be effective treatments for hirsutism, specially in short term. However in long term , using spironolactone may lead to a lower Ferriman-Galloway score comparing to other treatments. Treatment with spironolactone is also cost-effective.

In general combination of spironolactone and oral contraceptives in patients who doesn't respond to single therapy is more cost-effective comparing to other treatment combinations.